\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\ normal\\ except\\ for\\ po2\\ 73\\%\ \(0\)\
\-\ hr\\-\\ regular\\,\\ no\\ murmurs\ \(0\)\
\-\ lungs\\-\\ clear\\ bilaterally\\,\\ no\\ bruits\\,\\ no\\ wheezes\ \(0\)\
\-\ skin\\-\\ several\\ small\\ spider\\ like\\ lesions\\ on\\ upper\\ back\\,\\ perioral\\ cyanosis\\,\\ clubbing\\ of\\ fingers\\.\ \(0\)\
\-\ labs\\:\\ hemoglobin\\/hematocrit\\=\\ 17\\.8\\/53\ \(0\)\
\-\ the\\ patient\\ was\\ admitted\\ for\\ observation\\ and\\ further\\ workup\\ of\\ possible\\ genetic\\ disease\\.\\ a\\ ct\\ of\\ the\\ entire\\ abdomen\\ was\\ obtained\\ which\\ did\\ not\\ show\\ any\\ other\\ areas\\ of\\ avm\\'s\\.\\ \\ he\\ also\\ had\\ a\\ ct\\ scan\\ of\\ the\\ head\\ which\\ showed\\ a\\ small\\ enhancing\\ lesion\\ possibly\\ consistent\\ with\\ an\\ intracranial\\ avm\\.\\ \\ genetics\\ was\\ consulted\\ and\\ it\\ was\\ determined\\ that\\ the\\ pulmonary\\ avm\\'s\\ were\\ likely\\ congenital\\ and\\ associated\\ with\\ hereditary\\ hemorrhagic\\ telangiectasia\\.\\ \\ he\\ was\\ evaluated\\ by\\ interventional\\ radiology\\ and\\ plans\\ were\\ made\\ for\\ embolization\\ of\\ the\\ avm\\'s\\ in\\ the\\ near\\ future\\.\ \(0\)\
\-\ cxr\\ shows\\ opacities\\ present\\ in\\ both\\ lungs\\.\\ several\\ abnormal\\ vasculature\\ collections\\ with\\ dilated\\ arterial\\ supply\\ and\\ venous\\ drainage\\.\\ \\ one\\ in\\ the\\ right\\ lung\\ and\\ three\\ in\\ the\\ left\\ lung\\ of\\ varying\\ sizes\\.\ \(0\)\
\-\ pulmonary\\ arteriovenous\\ malformation\\-\\ hereditary\\ hemorrhagic\\ telangiectasias\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ pulmonary\\ arteriovenous\\ malformations\ \(2\)\
\-\ granulomatous\\ disease\ \(29\)\
\-\ pulmonary\\ nodules\ \(54\)\
\-\ 13\\ year\\ old\\ male\\ presenting\\ for\\ routine\\ visit\\ noted\\ to\\ have\\ oxygen\\ saturation\\ of\\ 73\\%\\.\\ the\\ mother\\ states\\ his\\ fingernails\\ have\\ always\\ been\\ bluish\\.\\ \\ he\\ has\\ had\\ nosebleeds\\ 2\\-3\\ times\\ a\\ month\\ since\\ age\\ 2\\.\\ \\ denies\\ difficulty\\ breathing\\ or\\ other\\ respiratory\\ symptoms\\.\ \(0\)\
\-\ fhx\\:\\ father\\ noted\\ to\\ have\\ several\\ telangiectasias\\ on\\ back\\ and\\ on\\ oral\\ mucosa\\.\ \(0\)\
\-\ hereditary\\ hemorrhagic\\ telangiectasia\\ also\\ known\\ as\\ rendu\\-osler\\-weber\\ syndome\\ is\\ an\\ autosomal\\ dominant\\ disorder\\ that\\ is\\ often\\ associated\\ with\\ pulmonary\\ arteriovenous\\ malformations\\.\\ hht\\ is\\ a\\ rare\\ disorder\\ that\\ was\\ formerly\\ thought\\ to\\ only\\ be\\ associated\\ with\\ benign\\ manifestations\\.\\ \\ it\\ is\\ now\\ recognized\\ however\\ that\\ there\\ may\\ be\\ more\\ severe\\ complications\\ of\\ the\\ disease\\.\\ \\ some\\ of\\ the\\ signs\\ and\\ symptoms\\ include\\:\ \(0\)\
\-\ epistaxis\ \(16\)\
\-\ hemoptysis\ \(61\)\
\-\ dyspnea\ \(130\)\
\-\ clubbing\\ of\\ digits\ \(0\)\
\-\ mucocutaneous\\ telangiectasias\ \(1\)\
\-\ gastrointestinal\\ bleeding\ \(5\)\
\-\ bruits\\/murmurs\ \(0\)\
\-\ high\\ output\\ chf\ \(0\)\
\-\ the\\ diagnosis\\ of\\ hht\\ requires\\ certain\\ criteria\\ be\\ met\\.\\ \\ the\\ criteria\\ are\\ as\\ follows\\:\ \(0\)\
\-\ recurrent\\ episodes\\ of\\ spontaneous\\ epistaxis\ \(0\)\
\-\ mucocutaneous\\ telangiectasias\ \(1\)\
\-\ visceral\\ avm\\'s\ \(0\)\
\-\ first\\ degree\\ relative\\ affected\\ in\\ autosomal\\ dominant\\ interitance\\ pattern\ \(0\)\
\-\ meeting\\ 3\\ or\\ more\\ criteria\\ is\\ sufficient\\ for\\ a\\ definite\\ diagnosis\\ of\\ hht\\.\\ \\ meeting\\ 2\\ out\\ of\\ 4\\ is\\ inconclusive\\ and\\ leads\\ to\\ the\\ designation\\ of\\ a\\ possible\\ diagnosis\\.\\ \\ if\\ less\\ than\\ 2\\ out\\ of\\ 4\\ criteria\\ are\\ met\\ then\\ the\\ diagnosis\\ is\\ unlikely\\.\\ \\ for\\ this\\ patient\\,\\ he\\ definitely\\ has\\ recurrent\\ episodes\\ of\\ epistaxis\\ by\\ history\\.\\ \\ the\\ ct\\ findings\\ of\\ pulmonary\\ avm\\'s\\ satisfies\\ the\\ visceral\\ avm\\ criteria\\.\\ \\ while\\ no\\ mucosal\\ lesions\\ were\\ seen\\ he\\ did\\ have\\ several\\ cutaneous\\ telangiectasias\\.\\ \\ his\\ father\\ did\\ not\\ have\\ a\\ strong\\ history\\ of\\ hht\\ but\\ did\\ have\\ the\\ mucocutaneous\\ telangiectasias\\.\\ \\ given\\ that\\ hht\\ sometimes\\ shows\\ incomplete\\ penetrance\\,\\ the\\ father\\ may\\ have\\ had\\ a\\ milder\\ form\\.\\ \\ thus\\ this\\ patient\\ has\\ unequivically\\ met\\ 2\\ out\\ of\\ the\\ 4\\ criteria\\ and\\ may\\ have\\ met\\ 3\\ or\\ 4\\ out\\ of\\ 4\\ depending\\ upon\\ how\\ liberal\\ one\\ is\\ with\\ judging\\ his\\ situation\\.\ \(0\)\
\-\ specific\\ to\\ this\\ patient\\'s\\ presentation\\ is\\ the\\ pulmonary\\ ateriovenous\\ malformations\\.\\ \\ pulmonary\\ avm\\'s\\ are\\ a\\ rare\\ condition\\ and\\ have\\ relatively\\ few\\ causes\\.\\ \\ 50\\-70\\%\\ of\\ pulmonary\\ avm\\'s\\ are\\ caused\\ by\\ hht\\.\\ \\ the\\ other\\ causes\\ include\\ hepatopulmonary\\ syndrome\\(hepatic\\ cirrhosis\\)\\,\\ trauma\\,\\ and\\ metastatic\\ thyroid\\ cancer\\.\\ \\ the\\ radiographic\\ findings\\ in\\ hht\\ are\\ usually\\ related\\ to\\ arteriovenous\\ malformations\\.\\ \\ chest\\ x\\-rays\\ are\\ usually\\ abnormal\\ in\\ patients\\ with\\ pulmonary\\ avm\\'s\\.\\ \\ these\\ cxr\\'s\\ have\\ a\\ round\\ mass\\ with\\ linear\\ vasculature\\ markings\\ entering\\ and\\ leaving\\.\\ \\ the\\ cxr\\ however\\ is\\ not\\ specific\\ in\\ differentiating\\ the\\ lesion\\ from\\ other\\ causes\\ of\\ masses\\ in\\ the\\ lungs\\.\\ \\ the\\ ct\\ scan\\ with\\ contrast\\ can\\ further\\ delineate\\ the\\ mass\\ by\\ showing\\ that\\ it\\ has\\ the\\ same\\ consitency\\ as\\ the\\ blood\\ vessels\\.\\ \\ often\\ the\\ dilated\\ artery\\ feeding\\ and\\ dilated\\ vein\\ draining\\ the\\ avm\\ can\\ be\\ identified\\.\\ \\ angiography\\ may\\ not\\ be\\ needed\\ for\\ diagnosis\\ but\\ can\\ definitely\\ demonstrate\\ the\\ vascular\\ nature\\ of\\ the\\ lesion\\ and\\ is\\ often\\ performed\\ durning\\ therapuetic\\ interventions\\.\\ other\\ studies\\ include\\ contrast\\ echocardiography\\,\\ radionuclide\\ perfusion\\ lung\\ scan\\,\\ shung\\ fraction\\ measurement\\,\\ and\\ mri\\.\ \(0\)\
\-\ as\\ alluded\\ to\\ previously\\ hht\\ is\\ being\\ recognized\\ as\\ a\\ cause\\ of\\ more\\ serious\\ morbidity\\ and\\ mortality\\ than\\ previously\\ thought\\.\\ some\\ of\\ the\\ more\\ serious\\ complications\\ are\\ tia\\,\\ cva\\,\\ and\\ brain\\ abscess\\,\\ all\\ thought\\ to\\ result\\ from\\ clots\\ bypassing\\ the\\ pulmonary\\ capillary\\ bed\\.\\ \\ other\\ complications\\ include\\ seizures\\,\\ intracerebral\\ hemorrhage\\,\\ especially\\ if\\ associated\\ with\\ intracranial\\ avm\\,\\ hemoptysis\\,\\ high\\ output\\ chf\\ from\\ shunting\\ and\\ polycythemia\\.\\ this\\ patient\\ does\\ not\\ currently\\ exhibit\\ any\\ of\\ these\\ more\\ serious\\ complications\\ but\\ does\\ have\\ clubbing\\ of\\ the\\ digits\\ which\\ is\\ suggestive\\ of\\ chronic\\ hypoxia\\.\ \(0\)\
\-\ the\\ treatment\\ of\\ pulmonary\\ avm\\'s\\ in\\ hht\\ is\\ aimed\\ at\\ preventing\\ the\\ more\\ serious\\ complications\\ of\\ the\\ disease\\,\\ i\\.e\\.\\ the\\ neurological\\ and\\ cardiopulmonary\\ complications\\.\\ treatment\\ for\\ large\\ avm\\'s\\ greater\\ than\\ 2\\ cm\\ in\\ diameter\\ or\\ with\\ a\\ feeding\\ artery\\ greater\\ than\\ 3\\ mm\\ in\\ diameter\\ is\\ either\\ surgical\\ ligation\\ or\\ intravascular\\ embolization\\.\\ embolization\\ is\\ the\\ preferred\\ method\\ as\\ this\\ spares\\ the\\ normal\\ lung\\ tissue\\ that\\ may\\ be\\ removed\\ or\\ damaged\\ in\\ surgical\\ resection\\.\\ \\ embolization\\ also\\ has\\ the\\ benefit\\ of\\ being\\ less\\ invasive\\ and\\ angiography\\ done\\ at\\ that\\ time\\ may\\ detect\\ other\\ lesions\\ in\\ need\\ of\\ treatment\\.\\ \\ small\\ lesions\\ may\\ not\\ need\\ to\\ be\\ treated\\ and\\ it\\ is\\ worth\\ restating\\ that\\ the\\ treatment\\ of\\ the\\ pulmonary\\ avm\\'s\\ is\\ done\\ to\\ reduce\\ the\\ risk\\ of\\ serious\\ strokes\\,\\ brain\\ abscesses\\,\\ and\\ other\\ neurological\\ complicaiton\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hht\\:\\ 0\\.06819634553500692\ \(0\)\
\-\ avm\\:\\ 0\\.05992450908353888\ \(0\)\
\-\ telangiectasias\\:\\ 0\\.04687207610628774\ \(0\)\
\-\ pulmonary\\:\\ 0\\.034127396459369956\ \(0\)\
\-\ criteria\\:\\ 0\\.02947876149889568\ \(0\)\
\-\ serious\\:\\ 0\\.02882920038796685\ \(0\)\
\-\ met\\:\\ 0\\.025162166477014854\ \(0\)\
\-\ \\'s\\:\\ 0\\.023773458906839684\ \(0\)\
\-\ have\\:\\ 0\\.021403595017892754\ \(0\)\
\-\ complications\\:\\ 0\\.02136386621458711\ \(0\)\
\-\ malformations\\:\\ 0\\.020073468585202724\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.01886344935301858\ \(0\)\
\-\ \\-mucocutaneous\\:\\ 0\\.01853947092316824\ \(0\)\
\-\ embolization\\:\\ 0\\.016737062111524797\ \(0\)\
\-\ other\\:\\ 0\\.016568988842922804\ \(0\)\
\-\ father\\:\\ 0\\.016094468003981673\ \(0\)\
\-\ hereditary\\:\\ 0\\.015468439806114674\ \(0\)\
\-\ meeting\\:\\ 0\\.014166302591559751\ \(0\)\
\-\ that\\:\\ 0\\.013968271879105584\ \(0\)\
\-\ may\\:\\ 0\\.0137963181727517\ \(0\)\
\-\ more\\:\\ 0\\.013483762203862248\ \(0\)\
\-\ definitely\\:\\ 0\\.013313589430448995\ \(0\)\
\-\ epistaxis\\:\\ 0\\.012989402932389567\ \(0\)\
\-\ did\\:\\ 0\\.012977575777046998\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.0125779327655022\ \(0\)\
\-\ he\\:\\ 0\\.012535159526987485\ \(0\)\
\-\ 4\\:\\ 0\\.012518253970447136\ \(0\)\
\-\ thought\\:\\ 0\\.012406045745678634\ \(0\)\
\-\ output\\:\\ 0\\.0122392978978181\ \(0\)\
\-\ telangiectasia\\:\\ 0\\.01213668977127881\ \(0\)\
\-\ out\\:\\ 0\\.011878249744935924\ \(0\)\
\-\ several\\:\\ 0\\.011554543998832335\ \(0\)\
\-\ cxr\\:\\ 0\\.011375496123422956\ \(0\)\
\-\ chf\\:\\ 0\\.011250857037154094\ \(0\)\
\-\ recognized\\:\\ 0\\.011186142718191414\ \(0\)\
\-\ clubbing\\:\\ 0\\.0111233604613046\ \(0\)\
\-\ digits\\:\\ 0\\.0111233604613046\ \(0\)\
\-\ 73\\:\\ 0\\.011062398238647917\ \(0\)\
\-\ is\\:\\ 0\\.010642727666587868\ \(0\)\
\-\ causes\\:\\ 0\\.010493945418958395\ \(0\)\
\-\ lung\\:\\ 0\\.010410763912676113\ \(0\)\
\-\ autosomal\\:\\ 0\\.010398143876043339\ \(0\)\
\-\ diagnosis\\:\\ 0\\.010316610571926498\ \(0\)\
\-\ include\\:\\ 0\\.010082664513271448\ \(0\)\
\-\ dilated\\:\\ 0\\.009795241030257503\ \(0\)\
\-\ vasculature\\:\\ 0\\.009760528189423471\ \(0\)\
\-\ be\\:\\ 0\\.009699576302216092\ \(0\)\
\-\ lesions\\:\\ 0\\.009621705599764238\ \(0\)\
\-\ than\\:\\ 0\\.009417660798815031\ \(0\)\
\-\ hemoglobin\\/hematocrit\\=\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ 17\\.8\\/53\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ malformation\\-\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ syndome\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ \\-epistaxis\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ \\-hemoptysis\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ \\-dyspnea\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ \\-clubbing\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ \\-gastrointestinal\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ \\-bruits\\/murmurs\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ \\-visceral\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ avm\\'s\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ \\-first\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ interitance\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ penetrance\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ unequivically\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ liberal\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ judging\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ hepatopulmonary\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ consitency\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ durning\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ shung\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ bypassing\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ restating\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ complicaiton\\:\\ 0\\.00926973546158412\ \(0\)\
\-\ feeding\\:\\ 0\\.009221244216873153\ \(0\)\
\-\ dominant\\:\\ 0\\.009171758417903238\ \(0\)\
\-\ angiography\\:\\ 0\\.00902992607133009\ \(0\)\
\-\ need\\:\\ 0\\.008962442759970468\ \(0\)\
\-\ episodes\\:\\ 0\\.008875706779877831\ \(0\)\
\-\ often\\:\\ 0\\.008600862929084076\ \(0\)\
\-\ are\\:\\ 0\\.008574255633761527\ \(0\)\
\-\ hr\\-\\:\\ 0\\.008540874072982705\ \(0\)\
\-\ lungs\\-\\:\\ 0\\.008540874072982705\ \(0\)\
\-\ \\-high\\:\\ 0\\.008540874072982705\ \(0\)\
\-\ \\-recurrent\\:\\ 0\\.008540874072982705\ \(0\)\
\-\ satisfies\\:\\ 0\\.008540874072982705\ \(0\)\
\-\ mucocutaneous\\:\\ 0\\.008540874072982705\ \(0\)\
\-\ therapuetic\\:\\ 0\\.008540874072982705\ \(0\)\
\-\ alluded\\:\\ 0\\.008540874072982705\ \(0\)\
\-\ associated\\:\\ 0\\.008481440849243752\ \(0\)\
\-\ has\\:\\ 0\\.008436908362220179\ \(0\)\
\-\ as\\:\\ 0\\.008155063128669576\ \(0\)\
\-\ skin\\-\\:\\ 0\\.008114517492427326\ \(0\)\
\-\ spider\\:\\ 0\\.008114517492427326\ \(0\)\
\-\ fingernails\\:\\ 0\\.008114517492427326\ \(0\)\
\-\ rendu\\-osler\\-weber\\:\\ 0\\.008114517492427326\ \(0\)\
\-\ ateriovenous\\:\\ 0\\.008114517492427326\ \(0\)\
\-\ spares\\:\\ 0\\.008114517492427326\ \(0\)\
\-\ it\\:\\ 0\\.008079278168382826\ \(0\)\
\-\ disorder\\:\\ 0\\.008073153904407831\ \(0\)\
\-\ perioral\\:\\ 0\\.0078120126843812905\ \(0\)\
\-\ nosebleeds\\:\\ 0\\.0078120126843812905\ \(0\)\
\-\ designation\\:\\ 0\\.0078120126843812905\ \(0\)\
\-\ polycythemia\\:\\ 0\\.0078120126843812905\ \(0\)\
\-\ not\\:\\ 0\\.007790654080390759\ \(0\)\
\-\ neurological\\:\\ 0\\.007776076995898514\ \(0\)\
\-\ his\\:\\ 0\\.007769366017813665\ \(0\)\
\-\ 2\\:\\ 0\\.007739661394366125\ \(0\)\
\-\ intracranial\\:\\ 0\\.00759518766958928\ \(0\)\
\-\ 50\\-70\\:\\ 0\\.00757737172611188\ \(0\)\
\-\ diameter\\:\\ 0\\.0075608046243705014\ \(0\)\
\-\ previously\\:\\ 0\\.00754946740326666\ \(0\)\
\-\ scan\\:\\ 0\\.007546597666981005\ \(0\)\
\-\ done\\:\\ 0\\.007450092251109887\ \(0\)\
\-\ specific\\:\\ 0\\.007428632376926414\ \(0\)\
\-\ bluish\\:\\ 0\\.007385656103825912\ \(0\)\
\-\ formerly\\:\\ 0\\.007385656103825912\ \(0\)\
\-\ disease\\:\\ 0\\.007343520195666163\ \(0\)\
\-\ treatment\\:\\ 0\\.00727493989316882\ \(0\)\
\-\ po2\\:\\ 0\\.007083151295779876\ \(0\)\
\-\ plans\\:\\ 0\\.007083151295779876\ \(0\)\
\-\ fhx\\:\\ 0\\.007083151295779876\ \(0\)\
\-\ milder\\:\\ 0\\.007083151295779876\ \(0\)\
\-\ aimed\\:\\ 0\\.007083151295779876\ \(0\)\
\-\ worth\\:\\ 0\\.007083151295779876\ \(0\)\
\-\ rare\\:\\ 0\\.006978654466189897\ \(0\)\
\-\ strokes\\:\\ 0\\.006959299523270534\ \(0\)\
\-\ the\\:\\ 0\\.006832509338664997\ \(0\)\
\-\ lungs\\:\\ 0\\.006805023339601\ \(0\)\
\-\ greater\\:\\ 0\\.006750192129696111\ \(0\)\
\-\ inconclusive\\:\\ 0\\.006656794715224497\ \(0\)\
\-\ clots\\:\\ 0\\.006656794715224497\ \(0\)\
\-\ situation\\:\\ 0\\.0065726278301839755\ \(0\)\
\-\ damaged\\:\\ 0\\.006494701466194784\ \(0\)\
\-\ genetics\\:\\ 0\\.006422153756955087\ \(0\)\
\-\ radionuclide\\:\\ 0\\.006422153756955087\ \(0\)\
\-\ intracerebral\\:\\ 0\\.006422153756955087\ \(0\)\
\-\ delineate\\:\\ 0\\.006354289907178461\ \(0\)\
\-\ tia\\:\\ 0\\.006354289907178461\ \(0\)\
\-\ or\\:\\ 0\\.0063187555139666085\ \(0\)\
\-\ 3\\:\\ 0\\.006312225636298232\ \(0\)\
\-\ \\%\\:\\ 0\\.006288078969545766\ \(0\)\
\-\ \\,\\:\\ 0\\.006262483113964587\ \(0\)\
\-\ being\\:\\ 0\\.006262435282440712\ \(0\)\
\-\ was\\:\\ 0\\.006235189414597393\ \(0\)\
\-\ small\\:\\ 0\\.006210016669971983\ \(0\)\
\-\ in\\:\\ 0\\.00620353440795328\ \(0\)\
\-\ for\\:\\ 0\\.0061334018813267305\ \(0\)\
\-\ does\\:\\ 0\\.006131695205854903\ \(0\)\
\-\ were\\:\\ 0\\.006120777087349909\ \(0\)\
\-\ bruits\\:\\ 0\\.00611964894890905\ \(0\)\
\-\ differentiating\\:\\ 0\\.00611964894890905\ \(0\)\
\-\ fraction\\:\\ 0\\.00611964894890905\ \(0\)\
\-\ preventing\\:\\ 0\\.00611964894890905\ \(0\)\
\-\ can\\:\\ 0\\.006114266096116938\ \(0\)\
\-\ less\\:\\ 0\\.006086098852413633\ \(0\)\
\-\ entering\\:\\ 0\\.006068344885639405\ \(0\)\
\-\ cva\\:\\ 0\\.006068344885639405\ \(0\)\
\-\ intravascular\\:\\ 0\\.006068344885639405\ \(0\)\
\-\ possible\\:\\ 0\\.0060525388409759665\ \(0\)\
\-\ leaving\\:\\ 0\\.006019427939651085\ \(0\)\
\-\ cardiopulmonary\\:\\ 0\\.006019427939651085\ \(0\)\
\-\ by\\:\\ 0\\.005984735660335961\ \(0\)\
\-\ visceral\\:\\ 0\\.005972685812867875\ \(0\)\
\-\ interventions\\:\\ 0\\.005972685812867875\ \(0\)\
\-\ exhibit\\:\\ 0\\.005972685812867875\ \(0\)\
\-\ back\\:\\ 0\\.00592863582617766\ \(0\)\
\-\ ligation\\:\\ 0\\.005927933326623083\ \(0\)\
\-\ sizes\\:\\ 0\\.005885007990639639\ \(0\)\
\-\ measurement\\:\\ 0\\.005885007990639639\ \(0\)\
\-\ had\\:\\ 0\\.005816560943976997\ \(0\)\
\-\ certain\\:\\ 0\\.005765840077593369\ \(0\)\
\-\ but\\:\\ 0\\.005749221769821885\ \(0\)\
\-\ echocardiography\\:\\ 0\\.005728940687676155\ \(0\)\
\-\ shunting\\:\\ 0\\.005728940687676155\ \(0\)\
\-\ further\\:\\ 0\\.005714919330810217\ \(0\)\
\-\ hypoxia\\:\\ 0\\.005693292368353672\ \(0\)\
\-\ any\\:\\ 0\\.005658959060088946\ \(0\)\
\-\ sufficient\\:\\ 0\\.005593071359095707\ \(0\)\
\-\ method\\:\\ 0\\.005593071359095707\ \(0\)\
\-\ lesion\\:\\ 0\\.005490710492114999\ \(0\)\
\-\ consulted\\:\\ 0\\.00547276604765749\ \(0\)\
\-\ morbidity\\:\\ 0\\.00547276604765749\ \(0\)\
\-\ some\\:\\ 0\\.005457262363547337\ \(0\)\
\-\ usually\\:\\ 0\\.005457262363547337\ \(0\)\
\-\ x\\-rays\\:\\ 0\\.005444723726856059\ \(0\)\
\-\ detect\\:\\ 0\\.005444723726856059\ \(0\)\
\-\ a\\:\\ 0\\.005421448394996652\ \(0\)\
\-\ wheezes\\:\\ 0\\.005417409861027184\ \(0\)\
\-\ brain\\:\\ 0\\.005407679333970057\ \(0\)\
\-\ fingers\\:\\ 0\\.0053907875603076355\ \(0\)\
\-\ interventional\\:\\ 0\\.0053907875603076355\ \(0\)\
\-\ benefit\\:\\ 0\\.005364822667993891\ \(0\)\
\-\ artery\\:\\ 0\\.005351272328303258\ \(0\)\
\-\ preferred\\:\\ 0\\.0053394834970379905\ \(0\)\
\-\ how\\:\\ 0\\.005314740597553034\ \(0\)\
\-\ also\\:\\ 0\\.005314257393281234\ \(0\)\
\-\ saturation\\:\\ 0\\.00529056655104967\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.00529056655104967\ \(0\)\
\-\ capillary\\:\\ 0\\.00529056655104967\ \(0\)\
\-\ cyanosis\\:\\ 0\\.005266935787798295\ \(0\)\
\-\ varying\\:\\ 0\\.005266935787798295\ \(0\)\
\-\ cutaneous\\:\\ 0\\.005221210118040421\ \(0\)\
\-\ strong\\:\\ 0\\.005221210118040421\ \(0\)\
\-\ bed\\:\\ 0\\.005221210118040421\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.005177390248008277\ \(0\)\
\-\ visit\\:\\ 0\\.005156146602038225\ \(0\)\
\-\ oxygen\\:\\ 0\\.005156146602038225\ \(0\)\
\-\ abnormal\\:\\ 0\\.005125325426529782\ \(0\)\
\-\ manifestations\\:\\ 0\\.005114905052981147\ \(0\)\
\-\ perfusion\\:\\ 0\\.005114905052981147\ \(0\)\
\-\ reduce\\:\\ 0\\.005075220165512328\ \(0\)\
\-\ abscesses\\:\\ 0\\.005075220165512328\ \(0\)\
\-\ this\\:\\ 0\\.005053297651493865\ \(0\)\
\-\ which\\:\\ 0\\.005032001852500153\ \(0\)\
\-\ ct\\:\\ 0\\.00502756531395181\ \(0\)\
\-\ leads\\:\\ 0\\.005018367146300681\ \(0\)\
\-\ however\\:\\ 0\\.0050039286132430505\ \(0\)\
\-\ supply\\:\\ 0\\.005000079299074742\ \(0\)\
\-\ future\\:\\ 0\\.004982104079979788\ \(0\)\
\-\ markings\\:\\ 0\\.004982104079979788\ \(0\)\
\-\ shows\\:\\ 0\\.004940849000481343\ \(0\)\
\-\ genetic\\:\\ 0\\.004913126916482614\ \(0\)\
\-\ mortality\\:\\ 0\\.004896567129975632\ \(0\)\
\-\ if\\:\\ 0\\.004876432037393555\ \(0\)\
\-\ one\\:\\ 0\\.004870097546394624\ \(0\)\
\-\ definite\\:\\ 0\\.004864209970494292\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.0048483972708470375\ \(0\)\
\-\ incomplete\\:\\ 0\\.0048483972708470375\ \(0\)\
\-\ murmurs\\:\\ 0\\.004832818842050885\ \(0\)\
\-\ collections\\:\\ 0\\.004832818842050885\ \(0\)\
\-\ breathing\\:\\ 0\\.004832818842050885\ \(0\)\
\-\ follows\\:\\ 0\\.004832818842050885\ \(0\)\
\-\ i\\.e\\:\\ 0\\.0048023377307225435\ \(0\)\
\-\ requires\\:\\ 0\\.004772715357466291\ \(0\)\
\-\ draining\\:\\ 0\\.004772715357466291\ \(0\)\
\-\ \\:\\:\\ 0\\.004754047596175247\ \(0\)\
\-\ mucosa\\:\\ 0\\.0047439046590560755\ \(0\)\
\-\ determined\\:\\ 0\\.004688548472425769\ \(0\)\
\-\ opacities\\:\\ 0\\.004688548472425769\ \(0\)\
\-\ these\\:\\ 0\\.00467685529328673\ \(0\)\
\-\ depending\\:\\ 0\\.004675153072028892\ \(0\)\
\-\ mucosal\\:\\ 0\\.004635961279392476\ \(0\)\
\-\ workup\\:\\ 0\\.004623215369263828\ \(0\)\
\-\ always\\:\\ 0\\.004623215369263828\ \(0\)\
\-\ observation\\:\\ 0\\.0046106221084365765\ \(0\)\
\-\ possibly\\:\\ 0\\.0045981778837814735\ \(0\)\
\-\ sometimes\\:\\ 0\\.0045737227185193635\ \(0\)\
\-\ except\\:\\ 0\\.004549823400877348\ \(0\)\
\-\ metastatic\\:\\ 0\\.004523889387205237\ \(0\)\
\-\ invasive\\:\\ 0\\.004514963035665045\ \(0\)\
\-\ patient\\:\\ 0\\.004503637912283849\ \(0\)\
\-\ to\\:\\ 0\\.004490726692355271\ \(0\)\
\-\ symptoms\\:\\ 0\\.004478774925127527\ \(0\)\
\-\ thus\\:\\ 0\\.004470210549420255\ \(0\)\
\-\ entire\\:\\ 0\\.0044168221946637625\ \(0\)\
\-\ of\\:\\ 0\\.00441023851601218\ \(0\)\
\-\ times\\:\\ 0\\.004356140472665185\ \(0\)\
\-\ and\\:\\ 0\\.004353530107088353\ \(0\)\
\-\ granulomatous\\:\\ 0\\.004336667236316882\ \(0\)\
\-\ vitals\\:\\ 0\\.004298770352528031\ \(0\)\
\-\ relative\\:\\ 0\\.004280322077395634\ \(0\)\
\-\ unlikely\\:\\ 0\\.004280322077395634\ \(0\)\
\-\ noted\\:\\ 0\\.0042595608589959906\ \(0\)\
\-\ nature\\:\\ 0\\.004253242691378374\ \(0\)\
\-\ states\\:\\ 0\\.00422684319492088\ \(0\)\
\-\ degree\\:\\ 0\\.004209604698837098\ \(0\)\
\-\ form\\:\\ 0\\.0042010902821887075\ \(0\)\
\-\ spontaneous\\:\\ 0\\.0041926442551674\ \(0\)\
\-\ like\\:\\ 0\\.004159522628396242\ \(0\)\
\-\ regular\\:\\ 0\\.004143345006062405\ \(0\)\
\-\ showing\\:\\ 0\\.004135348581892878\ \(0\)\
\-\ evaluated\\:\\ 0\\.004119535882245622\ \(0\)\
\-\ mother\\:\\ 0\\.00410395745344947\ \(0\)\
\-\ 13\\:\\ 0\\.004058560847912973\ \(0\)\
\-\ removed\\:\\ 0\\.004051181696852356\ \(0\)\
\-\ few\\:\\ 0\\.004043853968864876\ \(0\)\
\-\ contrast\\:\\ 0\\.00402266180190937\ \(0\)\
\-\ difficulty\\:\\ 0\\.004000928632881432\ \(0\)\
\-\ from\\:\\ 0\\.0039950653411804805\ \(0\)\
\-\ arterial\\:\\ 0\\.003933064783104807\ \(0\)\
\-\ needed\\:\\ 0\\.0039135312546369466\ \(0\)\
\-\ either\\:\\ 0\\.0039135312546369466\ \(0\)\
\-\ bleeding\\:\\ 0\\.0039007076236234673\ \(0\)\
\-\ near\\:\\ 0\\.003888038497949257\ \(0\)\
\-\ affected\\:\\ 0\\.003888038497949257\ \(0\)\
\-\ admitted\\:\\ 0\\.003881760719835162\ \(0\)\
\-\ round\\:\\ 0\\.003881760719835162\ \(0\)\
\-\ seizures\\:\\ 0\\.0038631491771438883\ \(0\)\
\-\ relatively\\:\\ 0\\.0038448613299179486\ \(0\)\
\-\ suggestive\\:\\ 0\\.0038388353838517183\ \(0\)\
\-\ findings\\:\\ 0\\.0038251039659094837\ \(0\)\
\-\ linear\\:\\ 0\\.0038092130105954656\ \(0\)\
\-\ radiology\\:\\ 0\\.00379759383479464\ \(0\)\
\-\ denies\\:\\ 0\\.0037918320411409858\ \(0\)\
\-\ recurrent\\:\\ 0\\.0037918320411409858\ \(0\)\
\-\ oral\\:\\ 0\\.00378610164706363\ \(0\)\
\-\ surgical\\:\\ 0\\.0037775431551029517\ \(0\)\
\-\ caused\\:\\ 0\\.003769095485922094\ \(0\)\
\-\ drainage\\:\\ 0\\.003757908947325821\ \(0\)\
\-\ condition\\:\\ 0\\.003757908947325821\ \(0\)\
\-\ hepatic\\:\\ 0\\.003752359991383819\ \(0\)\
\-\ respiratory\\:\\ 0\\.0037304524341778863\ \(0\)\
\-\ nodules\\:\\ 0\\.0037250461255549437\ \(0\)\
\-\ related\\:\\ 0\\.0037089920013375004\ \(0\)\
\-\ same\\:\\ 0\\.0037036946364269255\ \(0\)\
\-\ especially\\:\\ 0\\.003698423824835396\ \(0\)\
\-\ thyroid\\:\\ 0\\.003682768080888234\ \(0\)\
\-\ upon\\:\\ 0\\.0036724589325216506\ \(0\)\
\-\ presenting\\:\\ 0\\.003662249874554289\ \(0\)\
\-\ no\\:\\ 0\\.003619113147019146\ \(0\)\
\-\ vessels\\:\\ 0\\.003617497388309498\ \(0\)\
\-\ routine\\:\\ 0\\.0036029933692428994\ \(0\)\
\-\ made\\:\\ 0\\.0035792559117891255\ \(0\)\
\-\ currently\\:\\ 0\\.003560644369097852\ \(0\)\
\-\ result\\:\\ 0\\.003447091647684502\ \(0\)\
\-\ pattern\\:\\ 0\\.003434744836037096\ \(0\)\
\-\ radiographic\\:\\ 0\\.003410477804194252\ \(0\)\
\-\ studies\\:\\ 0\\.003355942079683659\ \(0\)\
\-\ clear\\:\\ 0\\.0033223203082509414\ \(0\)\
\-\ mm\\:\\ 0\\.003304095853622508\ \(0\)\
\-\ since\\:\\ 0\\.0033004885611968627\ \(0\)\
\-\ congenital\\:\\ 0\\.0032861818818532467\ \(0\)\
\-\ venous\\:\\ 0\\.0032616042255069707\ \(0\)\
\-\ risk\\:\\ 0\\.003254686274825538\ \(0\)\
\-\ vein\\:\\ 0\\.003251244292338714\ \(0\)\
\-\ identified\\:\\ 0\\.0032107960475145332\ \(0\)\
\-\ then\\:\\ 0\\.003197651817478538\ \(0\)\
\-\ obtained\\:\\ 0\\.0031943912731270683\ \(0\)\
\-\ signs\\:\\ 0\\.0031623301093439055\ \(0\)\
\-\ labs\\:\\ 0\\.003125104108238841\ \(0\)\
\-\ benign\\:\\ 0\\.0031009993344197698\ \(0\)\
\-\ presentation\\:\\ 0\\.0030950585010421474\ \(0\)\
\-\ given\\:\\ 0\\.0030803516219940507\ \(0\)\
\-\ now\\:\\ 0\\.0030716252257640877\ \(0\)\
\-\ cause\\:\\ 0\\.0030402340973206795\ \(0\)\
\-\ masses\\:\\ 0\\.003037426286010607\ \(0\)\
\-\ three\\:\\ 0\\.003029047558724406\ \(0\)\
\-\ areas\\:\\ 0\\.0030234986027824046\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.002990806082204033\ \(0\)\
\-\ cancer\\:\\ 0\\.0029539066922868195\ \(0\)\
\-\ bilaterally\\:\\ 0\\.002951319914325871\ \(0\)\
\-\ showed\\:\\ 0\\.002946165371107988\ \(0\)\
\-\ vascular\\:\\ 0\\.002946165371107988\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0028574596654051083\ \(0\)\
\-\ known\\:\\ 0\\.002843376534662271\ \(0\)\
\-\ abscess\\:\\ 0\\.002841047575325202\ \(0\)\
\-\ while\\:\\ 0\\.002827181114460897\ \(0\)\
\-\ enhancing\\:\\ 0\\.0028180373637063712\ \(0\)\
\-\ normal\\:\\ 0\\.00281727119789506\ \(0\)\
\-\ resection\\:\\ 0\\.0028022246640591153\ \(0\)\
\-\ severe\\:\\ 0\\.0027647842271987426\ \(0\)\
\-\ show\\:\\ 0\\.0027583132854801535\ \(0\)\
\-\ age\\:\\ 0\\.0027349214779645702\ \(0\)\
\-\ only\\:\\ 0\\.0027017998511934126\ \(0\)\
\-\ month\\:\\ 0\\.00269570403869675\ \(0\)\
\-\ treated\\:\\ 0\\.0026896433607611556\ \(0\)\
\-\ abdomen\\:\\ 0\\.0026618131050427933\ \(0\)\
\-\ syndrome\\:\\ 0\\.0025698281563981506\ \(0\)\
\-\ head\\:\\ 0\\.0025484766672701324\ \(0\)\
\-\ all\\:\\ 0\\.0025414547733241754\ \(0\)\
\-\ time\\:\\ 0\\.0025379613325334518\ \(0\)\
\-\ likely\\:\\ 0\\.00253447945944864\ \(0\)\
\-\ chronic\\:\\ 0\\.0025310090777150365\ \(0\)\
\-\ performed\\:\\ 0\\.002505339990775309\ \(0\)\
\-\ mass\\:\\ 0\\.0024993922333282114\ \(0\)\
\-\ an\\:\\ 0\\.002485099609431608\ \(0\)\
\-\ history\\:\\ 0\\.002482049500961269\ \(0\)\
\-\ high\\:\\ 0\\.0024590389706380814\ \(0\)\
\-\ trauma\\:\\ 0\\.0024574224834468233\ \(0\)\
\-\ blood\\:\\ 0\\.0024525878785586746\ \(0\)\
\-\ been\\:\\ 0\\.002444579273884323\ \(0\)\
\-\ at\\:\\ 0\\.0024348331289834554\ \(0\)\
\-\ cm\\:\\ 0\\.0024100484940241702\ \(0\)\
\-\ patients\\:\\ 0\\.0023255253410788914\ \(0\)\
\-\ both\\:\\ 0\\.0022946372141809898\ \(0\)\
\-\ on\\:\\ 0\\.002283567862351508\ \(0\)\
\-\ consistent\\:\\ 0\\.0022032579062368066\ \(0\)\
\-\ upper\\:\\ 0\\.0021683286071174745\ \(0\)\
\-\ chest\\:\\ 0\\.002150083070512638\ \(0\)\
\-\ tissue\\:\\ 0\\.0021297804294979953\ \(0\)\
\-\ demonstrate\\:\\ 0\\.002067773019277645\ \(0\)\
\-\ mri\\:\\ 0\\.00206443307562\ \(0\)\
\-\ present\\:\\ 0\\.002029451896878739\ \(0\)\
\-\ large\\:\\ 0\\.0019648185403060773\ \(0\)\
\-\ \\.\\:\\ 0\\.0017917746926105374\ \(0\)\
\-\ seen\\:\\ 0\\.001775633664634795\ \(0\)\
\-\ male\\:\\ 0\\.0016248218064011284\ \(0\)\
\-\ with\\:\\ 0\\.0013533606067179674\ \(0\)\
\-\ there\\:\\ 0\\.0013372403327707556\ \(0\)\
\-\ left\\:\\ 0\\.0010053683167959146\ \(0\)\
\-\ year\\:\\ 0\\.0010053683167959146\ \(0\)\
\-\ right\\:\\ 0\\.0009480880221981248\ \(0\)\
\-\ old\\:\\ 0\\.0009200153489613613\ \(0\)\
\-\ \\(\\:\\ 0\\.000759581205303744\ \(0\)\
\-\ \\)\\:\\ 0\\.0007503025153662514\ \(0\)\
